title: Complete remission of a metastatic neuroendocrine tumor of the pancreas with capecitabine (Xeloda) monotherapy.
authors: Tumor Center ZeTuP St.Gallen and Chur, Rorschacherstrasse 150, CH-9006 St Gallen, Switzerland. gfuerstenberger@sg.zetup.ch
authors: Gregor
authors: G
authors: Fürstenberger
authors: Peter
authors: P
authors: Schmid
authors: Ans
authors: A
authors: Duquesne
authors: Maria
authors: M
authors: Ammann
authors: Hans-Jörg
authors: HJ
authors: Senn
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D000069287:Capecitabine; D053379:Chromogranin A / Q000097:blood; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005472:Fluorouracil / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D018358:Neuroendocrine Tumors / Q000000981:diagnostic imaging / Q000188:drug therapy*; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*; D014057:Tomography, X-Ray Computed
chemical_list: D000964:Antimetabolites, Antineoplastic; D053379:Chromogranin A; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil